Efficacy and tolerability of ezetimibe add-on therapy in bile acid sequestrant/niacin-based regimen
Publication
, Conference
Chiou, P; Xydakis, AM; Guyton, JR; Stein, JL; Jones, PH; Ballantyne, CM
Published in: ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
May 1, 2004
Duke Scholars
Published In
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
ISSN
1079-5642
Publication Date
May 1, 2004
Volume
24
Issue
5
Start / End Page
E82 / E82
Location
San Francisco, CA
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Conference Name
5th Annual Conference on Arteriosclerosis, Thrombosis, and Vascular Biology
Related Subject Headings
- Cardiovascular System & Hematology
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Chiou, P., Xydakis, A. M., Guyton, J. R., Stein, J. L., Jones, P. H., & Ballantyne, C. M. (2004). Efficacy and tolerability of ezetimibe add-on therapy in bile acid sequestrant/niacin-based regimen. In ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (Vol. 24, pp. E82–E82). San Francisco, CA: LIPPINCOTT WILLIAMS & WILKINS.
Chiou, P., A. M. Xydakis, J. R. Guyton, J. L. Stein, P. H. Jones, and C. M. Ballantyne. “Efficacy and tolerability of ezetimibe add-on therapy in bile acid sequestrant/niacin-based regimen.” In ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 24:E82–E82. LIPPINCOTT WILLIAMS & WILKINS, 2004.
Chiou P, Xydakis AM, Guyton JR, Stein JL, Jones PH, Ballantyne CM. Efficacy and tolerability of ezetimibe add-on therapy in bile acid sequestrant/niacin-based regimen. In: ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. LIPPINCOTT WILLIAMS & WILKINS; 2004. p. E82–E82.
Chiou, P., et al. “Efficacy and tolerability of ezetimibe add-on therapy in bile acid sequestrant/niacin-based regimen.” ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, vol. 24, no. 5, LIPPINCOTT WILLIAMS & WILKINS, 2004, pp. E82–E82.
Chiou P, Xydakis AM, Guyton JR, Stein JL, Jones PH, Ballantyne CM. Efficacy and tolerability of ezetimibe add-on therapy in bile acid sequestrant/niacin-based regimen. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. LIPPINCOTT WILLIAMS & WILKINS; 2004. p. E82–E82.
Published In
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
ISSN
1079-5642
Publication Date
May 1, 2004
Volume
24
Issue
5
Start / End Page
E82 / E82
Location
San Francisco, CA
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Conference Name
5th Annual Conference on Arteriosclerosis, Thrombosis, and Vascular Biology
Related Subject Headings
- Cardiovascular System & Hematology
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology